189
Participants
Start Date
December 1, 2020
Primary Completion Date
November 7, 2024
Study Completion Date
February 6, 2025
Triamcinolone Hexacetonide 20 MG/ML
JIA patients (age 1-18 years) starting TNFi treatment randomised to intervention will receive treatment with intra articular glucocorticoids (triamcinolone hexacetonide) injections in inflamed joints
Haukeland University Hospital, Bergen
University Hospital of North Norway, Tromsø
Oslo University Hospital, Oslo
St Olavs Hospital, Trondheim
Stavanger University Hospital, Stavanger
The Research Council of Norway
OTHER
Haukeland University Hospital
OTHER
St. Olavs Hospital
OTHER
University Hospital of North Norway
OTHER
Helse Stavanger HF
OTHER_GOV
Oslo University Hospital
OTHER